PHYSIOLOGIC, BASAL INSULIN, INTERACTIVE (ARS) CASE MANGEMEMENT SESSION # 3: Presentations, interactive discussion, and evaluation of two patients who have been on various insulin formulations — including NPH and basal insulin and with drug administration and dosing issues—who present with specific clinical profiles, safety needs, and glycemic dysregulation issues that make them ideal candidates for a long-acting physiologic insulin and for switching from one kind of insulin regimen to another.

PHYSIOLOGIC, BASAL INSULIN, INTERACTIVE (ARS) CASE MANGEMEMENT SESSION # 3: Presentations, interactive discussion, and evaluation of two patients who have been on various insulin formulations — including NPH and basal insulin and with drug administration and dosing issues—who present with specific clinical profiles, safety needs, and glycemic dysregulation issues that make them ideal candidates for a long-acting physiologic insulin and for switching from one kind of insulin regimen to another.


Published

April 30, 2018

Created by

CMEducation Resources symposium